ICYMI: Allopurinol Safety in CKD Patients
Jul 06, 2022
Latest ACR News
A study in the Annals of Internal Medicine reports chronic kidney disease (CKD) patients can be safely treated with allopurinol without an increased risk of mortality.Read Article
Making Better Posters: Dr. David Liew Dr. David Liew describes how some presenters are working to make their posters better design-wise to improve their presentation at the 2019 ACR/ARP annual meeting in Atlanta.
Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
SJIA-associated ILD: Dr. Jonathan Hausmann Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta.
Lupus Pearls: Dr. Kathryn Dao Dr. Dao reviews several lupus pearls presented by Dr. Michelle Petri at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Gout Drs. Jack Cush, Nicola Dalbeth, Ken Saag, and Robert Keenan discuss key presentations related to gout presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Studies on the Changing Face of RA: Dr. Janet Pope Dr. Pope discusses abstract #171, #172 and #841 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Rheumatoid Arthritis Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.
Drug Levels Associated with Lupus Flares: Dr. Janet Pope: Dr. Pope discusses abstract #2567 Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates presented at the 2019 ACR/ARP annual meeting in Atlanta.
Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.
Dr. Dao talks with Dr. Gwenesta Melton about Women in Rheumatology Dr. Dao interviews Dr. Melton about Women in Rheumatology
Social Media Professionalism: Dr. Michael Putman and Dr. Jilaine Bolek Berquist Dr. Michael Putman talks with Dr. Jilaine Bolek Berquist about her talk on tweets and trolls in social media at the 2019 ACR/ARP annual meeting in Atlanta.
Domain Strategy and Treatment in Psoriatic Arthritis: Dr. Elaine Husni Dr. Elaine Husni reviews her talk on domain strategies in PsA at the 2019 ACR/ARP annual meeting in Atlanta.
